Lois Resnick‐Silverman

990 total citations
18 papers, 728 citations indexed

About

Lois Resnick‐Silverman is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Lois Resnick‐Silverman has authored 18 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 5 papers in Biotechnology. Recurrent topics in Lois Resnick‐Silverman's work include Cancer-related Molecular Pathways (14 papers), Cancer Research and Treatments (5 papers) and Ubiquitin and proteasome pathways (5 papers). Lois Resnick‐Silverman is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Cancer Research and Treatments (5 papers) and Ubiquitin and proteasome pathways (5 papers). Lois Resnick‐Silverman collaborates with scholars based in United States, Sweden and France. Lois Resnick‐Silverman's co-authors include James J. Manfredi, Luis A. Carvajal, Selvon St. Clair, Luciana E. Giono, Dana J. Lukin, Melissa Mattia, S.X. Yan, Wenjun Liu, Sachchidanand Sachchidanand and Lei Zeng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Lois Resnick‐Silverman

18 papers receiving 715 citations

Peers

Lois Resnick‐Silverman

ONCOL

PRM

HEMAT

Luis A. Carvajal United States

Liz J. Valente Australia

Isao Kinoyama Japan

Irit Snir-Alkalay Israel

Mercè de Frías Spain

Astrid Voigt Germany

Gilles Doumont Belgium

Heriberto Bruzzoni‐Giovanelli France

Nicholas T. Woods United States

Mayuko Omori United States

Luis A. Carvajal United States

Lois Resnick‐Silverman

550 ×1.1

354 ×1.1

ONCOL

134 ×1.4

49 ×0.6

PRM

92 ×1.7

HEMAT

Citations per year, relative to Lois Resnick‐Silverman Lois Resnick‐Silverman (= 1×) peers Luis A. Carvajal

Countries citing papers authored by Lois Resnick‐Silverman

Since Specialization

Citations

This map shows the geographic impact of Lois Resnick‐Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois Resnick‐Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois Resnick‐Silverman more than expected).

Fields of papers citing papers by Lois Resnick‐Silverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois Resnick‐Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois Resnick‐Silverman. The network helps show where Lois Resnick‐Silverman may publish in the future.

Co-authorship network of co-authors of Lois Resnick‐Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Lois Resnick‐Silverman. A scholar is included among the top collaborators of Lois Resnick‐Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois Resnick‐Silverman. Lois Resnick‐Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rahmé, Ramy, et al.. (2025). Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild type. EMBO Reports. 26(5). 1315–1343. 1 indexed citations

Efe, Gizem, Karen J. Dunbar, Kensuke Sugiura, et al.. (2023). p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression. Cancer Discovery. 13(12). 2632–2651. 30 indexed citations

Resnick‐Silverman, Lois, et al.. (2023). In vivo RNA-seq and ChIP-seq analyses show an obligatory role for the C terminus of p53 in conferring tissue-specific radiation sensitivity. Cell Reports. 42(3). 112216–112216. 9 indexed citations

Hashimoto, Hideharu, Yingtao Bi, Ramana V. Davuluri, et al.. (2021). Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates. Nature Communications. 12(1). 484–484. 22 indexed citations

Pappas, Kyrie, Jia Xu, Sakellarios Zairis, et al.. (2017). p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes. Molecular Cancer Research. 15(8). 1051–1062. 48 indexed citations

Giono, Luciana E., Lois Resnick‐Silverman, Luis A. Carvajal, Selvon St. Clair, & James J. Manfredi. (2017). Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase. Oncogene. 36(49). 6762–6773. 45 indexed citations

Mellert, Hestia, Morgan A. Sammons, Stephen M. Sykes, et al.. (2016). A rare DNA contact mutation in cancer confers p53 gain‐of‐function and tumor cell survival via TNFAIP8 induction. Molecular Oncology. 10(8). 1207–1220. 26 indexed citations

Lukin, Dana J., et al.. (2014). p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints. Molecular Cancer Research. 13(1). 16–28. 69 indexed citations

Mosoyan, Goar, Chandandeep Nagi, Svetlana Marukian, et al.. (2013). Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential. PLoS ONE. 8(1). e55145–e55145. 15 indexed citations

10.

Chander, Harish, et al.. (2011). Skp2B Overexpression Alters a Prohibitin-p53 Axis and the Transcription of PAPP-A, the Protease of Insulin-Like Growth Factor Binding Protein 4. PLoS ONE. 6(8). e22456–e22456. 29 indexed citations

11.

Resnick‐Silverman, Lois & James J. Manfredi. (2011). Analyzing p53 Regulated DNA Damage Checkpoints by Flow Cytometry. Methods in molecular biology. 782. 193–203. 1 indexed citations

12.

Chander, Harish, et al.. (2010). Skp2B attenuates p53 function by inhibiting prohibitin. EMBO Reports. 11(3). 220–225. 28 indexed citations

13.

Sachchidanand, Sachchidanand, Lois Resnick‐Silverman, S.X. Yan, et al.. (2006). Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein Association. Chemistry & Biology. 13(1). 81–90. 107 indexed citations

14.

Resnick‐Silverman, Lois & James J. Manfredi. (2006). Gene‐specific mechanisms of p53 transcriptional control and prospects for cancer therapy. Journal of Cellular Biochemistry. 99(3). 679–689. 21 indexed citations

15.

Manfredi, James J., Jianli Dong, Lois Resnick‐Silverman, et al.. (2005). Evidence against a Role for SV40 in Human Mesothelioma. Cancer Research. 65(7). 2602–2609. 72 indexed citations

16.

Clair, Selvon St., Luciana E. Giono, Lois Resnick‐Silverman, et al.. (2004). DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms. Molecular Cell. 16(5). 725–736. 128 indexed citations

17.

Buschmann, Thomas, Yahong Lin, Serge Y. Fuchs, et al.. (2001). Stabilization and Activation of p53 by the Coactivator Protein TAFII31. Journal of Biological Chemistry. 276(17). 13852–13857. 36 indexed citations

18.

Resnick‐Silverman, Lois, et al.. (1991). Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts. Journal of Virology. 65(6). 2845–2852. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact